We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Small Nucleolar RNA and C/D Box 15B Regulate the TRIM25/P53 Complex to Promote the Development of Endometrial Cancer.
- Authors
Wen, Jing-tao; Chen, Xi; Liu, Xin; Xie, Bu-min; Chen, Jing-wen; Qin, Hong-lei; Zhao, Yang
- Abstract
Background. Endometrial cancer is associated with a high mortality rate, which warrants the identification of novel diagnostic markers and therapeutic targets. The aim of this study is to evaluate the role of SNORD15B in the development of endometrial cancer and explore the potential underlying mechanisms. Methods. Bioinformatics was used to analyze the expression level and prognostic relevance of SNORD15B in endometrial cancer. The Ishikawa and HEC-1B cells were respectively transfected with SNORD15B expression plasmid and an antisense oligonucleotide, or the corresponding empty vector and a nonspecific sequence. The malignant phenotype of the suitably transfected cells was assessed by standard in vitro functional assays and the establishment of in vivo xenografts. The expression levels of the specific markers were analyzed with RT-qPCR and western blotting. The subcellular localization of P53 was determined by analyzing the nuclear and cytoplasmic fractions. RIP, Co-IP, and immunohistochemistry were performed as per standard protocols. Results. SNORD15B was overexpressed in the endometrial cancer tissues and correlated to a poor prognosis. Ectopic expression of SNORD15B in Ishikawa cells inhibited apoptosis, increased the proliferation, invasion, and migration in vitro, and enhanced their tumorigenicity in vivo. SNORD15B overexpression also upregulated TRIM25 and accelerated P53 accumulation in the cytoplasm of the endometrial cancer cells. Conclusion. SNORD15B functions as an oncogene in endometrial cancer by targeting the TRIM25/P53 complex and blocking the nuclear translocation of P53.
- Subjects
CHINA; RNA analysis; DISEASE progression; IN vitro studies; MOLECULAR diagnosis; XENOGRAFTS; IN vivo studies; ANIMAL experimentation; WESTERN immunoblotting; IMMUNOHISTOCHEMISTRY; CANCER invasiveness; APOPTOSIS; RISK assessment; BIOINFORMATICS; GENE expression; CELLULAR signal transduction; ENDOMETRIAL tumors; TUMOR suppressor genes; CELL proliferation; TUMOR markers; CELL lines; POLYMERASE chain reaction; MICE; PHENOTYPES; DISEASE risk factors
- Publication
Journal of Oncology, 2022, p1
- ISSN
1687-8450
- Publication type
Article
- DOI
10.1155/2022/7762708